Hanmi Pharm. Co., Ltd.
KRX:128940.KS
323500 (KRW) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,490,887.464 | 1,331,546.6 | 1,203,185.653 | 1,075,853.605 | 1,113,649.784 | 1,015,962.25 | 916,586.235 | 882,724.835 | 1,317,534.519 | 761,279.849 | 730,133.51 | 674,005.087 | 606,192.087 | 337,380.097 |
| Cost of Revenue
| 655,030.746 | 612,993.54 | 570,433.411 | 494,935.311 | 481,167.542 | 475,046.696 | 398,182.018 | 421,869.255 | 398,250.966 | 338,776.803 | 313,679.683 | 279,326.076 | 271,856.794 | 142,347.3 |
| Gross Profit
| 835,856.718 | 718,553.06 | 632,752.241 | 580,918.294 | 632,482.242 | 540,915.554 | 518,404.216 | 460,855.58 | 919,283.553 | 422,503.046 | 416,453.826 | 394,679.011 | 334,335.292 | 195,032.797 |
| Gross Profit Ratio
| 0.561 | 0.54 | 0.526 | 0.54 | 0.568 | 0.532 | 0.566 | 0.522 | 0.698 | 0.555 | 0.57 | 0.586 | 0.552 | 0.578 |
| Reseach & Development Expenses
| 192,226.97 | 154,316.776 | 146,027.429 | 212,387.105 | 194,288.043 | 165,905.667 | 151,288.986 | 142,894.305 | 167,987.152 | 135,167.92 | 94,965.049 | 79,986.795 | 70,515.495 | 32,083.366 |
| General & Administrative Expenses
| 65,216.594 | 61,328.391 | 61,793.427 | 47,478.044 | 62,610.649 | 58,856.974 | 58,387.871 | 47,534.004 | 54,716.888 | 53,025.283 | 57,924.367 | 64,069.309 | 61,119.122 | 54,328.814 |
| Selling & Marketing Expenses
| 183,026.434 | 172,305.507 | 151,586.559 | 134,463.627 | 128,348.92 | 110,904.467 | 111,421.964 | 124,498.507 | 260,560.497 | 80,946.476 | 93,003.951 | 89,563.524 | 69,657.629 | 47,874.814 |
| SG&A
| 418,744.832 | 233,633.898 | 213,379.986 | 181,941.671 | 190,959.569 | 169,761.441 | 169,809.835 | 172,032.511 | 315,277.385 | 133,971.759 | 150,928.318 | 153,632.833 | 130,776.751 | 102,203.628 |
| Other Expenses
| 12,396.214 | 172,512.074 | 147,928.952 | 137,613.176 | 143,356.784 | 121,674.87 | -4,110.451 | 12,118.216 | 17,454.495 | 11,635.806 | 6,930.138 | 2,525.718 | 8.772 | 757.611 |
| Operating Expenses
| 610,971.803 | 560,462.748 | 507,336.367 | 531,941.952 | 528,604.396 | 457,341.978 | 436,240.54 | 434,083.715 | 707,483.578 | 388,051.032 | 354,558.582 | 346,535.663 | 310,058.253 | 198,834.604 |
| Operating Income
| 224,884.915 | 158,090.311 | 125,415.875 | 48,976.342 | 103,877.846 | 83,573.576 | 82,163.676 | 26,771.865 | 211,799.976 | 34,452.014 | 61,895.245 | 48,143.348 | 22,676.724 | -3,801.809 |
| Operating Income Ratio
| 0.151 | 0.119 | 0.104 | 0.046 | 0.093 | 0.082 | 0.09 | 0.03 | 0.161 | 0.045 | 0.085 | 0.071 | 0.037 | -0.011 |
| Total Other Income Expenses Net
| -29,617.272 | -37,077.785 | -21,719.354 | -26,845.931 | -20,608.198 | -33,218.776 | -23,314.173 | -18,774.126 | -2,215.462 | 2,008.771 | -7,066.293 | -15,938.787 | -17,826.68 | -9,236.537 |
| Income Before Tax
| 195,267.643 | 121,012.527 | 103,696.521 | 22,130.411 | 83,269.649 | 50,354.801 | 58,849.503 | 7,997.739 | 209,584.513 | 36,460.785 | 54,828.951 | 32,204.561 | 6,450.359 | -13,038.344 |
| Income Before Tax Ratio
| 0.131 | 0.091 | 0.086 | 0.021 | 0.075 | 0.05 | 0.064 | 0.009 | 0.159 | 0.048 | 0.075 | 0.048 | 0.011 | -0.039 |
| Income Tax Expense
| 28,600.596 | 19,454.334 | 22,218.297 | 4,840.696 | 19,402.401 | 16,198.635 | -10,124.078 | -22,301.909 | 47,524.066 | -6,834.285 | 4,294.503 | 3,449.813 | 1,024.338 | -4,101.44 |
| Net Income
| 146,231.158 | 82,791.735 | 67,025.376 | 17,289.715 | 52,109.663 | 34,156.166 | 60,434.212 | 23,325.623 | 154,443.35 | 35,509.506 | 43,933.276 | 22,636.854 | 1,291.575 | -12,698.688 |
| Net Income Ratio
| 0.098 | 0.062 | 0.056 | 0.016 | 0.047 | 0.034 | 0.066 | 0.026 | 0.117 | 0.047 | 0.06 | 0.034 | 0.002 | -0.038 |
| EPS
| 11,522 | 6,517.2 | 5,269.74 | 1,357.83 | 4,008.72 | 2,735.74 | 4,965.22 | 1,860.59 | 12,307 | 2,793.93 | 3,594.63 | 1,978.67 | 118.42 | -1,164.56 |
| EPS Diluted
| 11,522 | 6,517.2 | 5,269.74 | 1,357.83 | 4,008.72 | 2,735.74 | 4,965.22 | 1,860.59 | 12,307 | 2,793.93 | 3,594.63 | 1,978.67 | 118.42 | -1,164.56 |
| EBITDA
| 323,338.895 | 256,032.768 | 212,471.952 | 119,314.154 | 167,672.692 | 118,769.477 | 107,401.574 | 97,444.971 | 285,357.841 | 76,797.352 | 99,336.8 | 86,100.005 | 62,408.429 | 20,072.256 |
| EBITDA Ratio
| 0.217 | 0.192 | 0.177 | 0.111 | 0.151 | 0.117 | 0.117 | 0.11 | 0.217 | 0.101 | 0.136 | 0.128 | 0.103 | 0.059 |